Net profit of Shukra Pharmaceuticals declined 88.54% to Rs 0.54 crore in the quarter ended September 2024 as against Rs 4.71 crore during the previous quarter ended September 2023. Sales declined 77.44% to Rs 5.56 crore in the quarter ended September 2024 as against Rs 24.64 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 5.56 | 24.64 | -77 |
| OPM % | 12.05 | 20.62 | - |
| PBDT | 1.58 | 5.26 | -70 |
| PBT | 0.88 | 4.70 | -81 |
| NP | 0.54 | 4.71 | -89 |